Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»BioTech»Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa
    BioTech

    Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa

    Marie JonesBy Marie JonesDecember 24, 2025Updated:December 26, 2025No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced the appointment of Gladys Wang as Vice President, Bioprocessing Commercial for Asia, Middle East and Africa (AMEA). With over twenty years of experience in life sciences and commercial leadership, Gladys will oversee Avantor’s business expansion in the AMEA region, enhance customer success initiatives, and drive the development of strategic partnerships throughout the bioprocessing ecosystem.

    Gladys, based in Singapore, has extensive experience collaborating with biopharma manufacturers, contract development and manufacturing organizations (CDMOs), and key opinion leaders. She is widely recognized for her expertise in delivering transformative business results through customer-centric strategies, operational excellence, and effective cross-market collaboration.

    Before joining Avantor, Gladys held senior leadership roles at top life sciences organizations, including Head of Global Strategic Accounts APAC and Senior Director for Bioprocessing South Asia & Oceania. She was instrumental in accelerating Asia-Pacific expansion, delivering material business growth through disciplined market-entry strategy.

    “The Asia, Middle East and Africa region is full of potential, and being part of a team that partners so closely with customers to advance innovation and strengthen manufacturing capabilities is truly motivating. The focus ahead will be on deepening collaboration, enhancing customer experience, and empowering teams to deliver meaningful impact across the bioprocessing value chain. Contributing to Avantor’s continued growth and supporting customers in reaching their scientific and operational objectives is an exciting prospect,” said Gladys Wang, Vice President, Bioprocessing Commercial, Asia, Middle East & Africa.

    Gladys holds a Master’s degree in Biology from National Taiwan University and has completed executive programs at INSEAD and Stanford University, specializing in strategic transformation and innovation.

    With her commitment to excellence and talent for cultivating future leaders, Gladys will further strengthen Avantor’s position as a trusted partner for bioprocessing customers across the AMEA region.

    About Avantor®

    Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

    Regional Media Contact:
    Swati Chhabra
    Manager – Corporate Communications, AMEA
    Avantor
    91-9958-404-334
    Swati.Chhabra@avantorsciences.com

    Global Media Contact
    Eric Van Zanten
    Head – External Communications
    Avantor
    610-529-6219
    Eric.Vanzanten@avantorsciences.com

    Avantor
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleAEON Credit Service Net Profit Surges 28.1% to HK$352.7 Million for First Nine Months of FY2025/26
    Next Article BCQ (01963.HK) to Pay RMB 585 Million Cash Dividend, Driving Share Price and Yield Upside

    Related Posts

    CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

    June 8, 2026

    Focus Graphite Completes Air Quality Assessment for the Lac Knife Project; Advancing Towards ESIA Completion

    June 8, 2026

    iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival

    June 7, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.